Search results
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 6 hours agoIndia Breakthrough: Bio Regenerative Precision Medicine Seminar Held in Hyderabad PR Newswire HYDERABAD, India, June 10, 2024 HYDERABAD, India, June 10, 2024 /PRNewswire/ ...
Octane Medical acquires B. Braun’s global orthobiologics business
Digital Journal· 3 days agoOctane Medical Group, through its new venture Octane Biotherapeutics (BioTx), has acquired 100% shares of the global orthobiologics business from its long-term partner B. Braun. The acquisition ...
FibroBiologics Shares Up 38% on Withdrawn Equity Offering
Market Watch· 4 days agoFibroBiologics shares rose Thursday after the cell therapy and regenerative medicine company said it will no longer pursue a planned equity offering. The ...
Celularity reports advances in cancer T-cell therapy By Investing.com
Investing.com· 7 days agoCelularity Inc. (NASDAQ: CELU), a biotechnology firm specializing in regenerative medicine,...
Longeveron enters contract manufacturing with Secretome deal By Investing.com
Investing.com· 7 days agoLongeveron Inc. (NASDAQ: LGVN), a biotech company specializing in regenerative medicine, has...
ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and...
Benzinga· 2 hours agoNEWSWIRE) -- ProKidney Corp. PROK ("ProKidney"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced positive interim results ...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 7 days agoLongeveron (NASDAQ: LGVN) is a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions ...
Ocugen (OCGN) Skyrockets 209.6% Year to Date: Heres Why
Zacks via Yahoo Finance· 5 days agoAn update on the clinical study is expected in the third quarter of 2024. Apart from these, Ocugen’s...
Skin models as an alternative to animal testing
Medical Xpress· 7 days agoTigerShark Science, a planned Fraunhofer start-up and spin-off of the Fraunhofer Translational Center for Regenerative Therapies TLC-RT at the Fraunhofer...
Greater Boston’s last remaining salt marsh is in danger. Again. - The Boston Globe
The Boston Globe· 17 hours agoA volunteer-led group of residents — the Friends of Belle Isle Marsh — have fought for the area’s...
